The COVID-19 pandemic has rapidly changed how we live, work and learn. First and foremost, I want to assure everyone that the safety of older adults, a population known to be at high risk, is paramount to NIH and NIA leadership.
A few years ago, NIA collaborated with the Agency for Healthcare Research and Quality (AHRQ) and the National Academies of Sciences, Engineering, and Medicine (NASEM) to assess the evidence for
As John Lennon once sang, “Life is what happens to you while you’re busy making other plans.” This famous adage rings true in scientific careers, where critical life events — the arrival of a child or a loved one’s illness and caregiving responsibilities — often pause a promising career.
Most older adults develop chronic medical conditions over time, which can mean greater vulnerability to intermittent illnesses and/or injuries.
Since Dr. Alois Alzheimer first studied the brain of Auguste D., research on brain tissue has been crucial to advancing understanding of Alzheimer’s disease and related dementias (AD/ADRD).
Estimates suggest that as many as 5.5 million older Americans — and many more under age 65 — are living with Alzheimer’s disease, with another 1 million Americans affected by related dementias such as frontotemporal, Lewy body, vascular, and mixed dementias.
Genetics, data privacy, personalized medicine, end-of-life decision making, health disparities and palliative care. What do these have in common?
The NIA Office of Small Business Research (OSBR) team is intrigued by startups and their unique role in research and development.
NIA is happy to unveil our latest collection of cleared concepts for funding opportunity announcements (FOAs).
We have posted NIA’s updated funding lines for fiscal year 2020!
NIA Blog Team
It may be winter, but our thoughts are already turning to summer.
